Literature DB >> 19196502

Association between ischaemic heart disease and interstitial lung disease: a case-control study.

A Ponnuswamy1, R Manikandan, A Sabetpour, I M Keeping, J P Finnerty.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is increasing in incidence. One of the authors noted that many of his patients with IPF were taking statins, and suspected an association. A case-control study was undertaken to investigate the association of statins with interstitial lung disease.
METHODS: The study population comprised patients attending the respiratory outpatients diagnosed with IPF between the beginning of 1999 and the beginning of July 2004, and 50 cases were identified. Data regarding the age, sex, smoking habits, occupational histories, exposure to birds, co-morbidity (ischaemic heart disease, diabetes, atrial fibrillation, and hyperlipidaemia), biopsy evidence for IPF, and use of beta blockers, statins, aspirin, NSAIDS, loop diuretics and proton pump inhibitors were recorded. Two age and sex-matched controls were obtained for each case from patients attending a general gastroenterology clinic within 3 months of attendance of the case, and thus 100 controls were obtained. Data on the controls were collected as for the cases.
RESULTS: Of the cases, 12 of 50 were taking statins compared with 20 of 100 controls (matched OR 1.13, CI 0.30-4.24, NS). Coronary artery disease was seen in 20 of 50 cases and 20 of 100 controls (matched OR 5.37, CI 1.52-19.0, p<0.01).
CONCLUSIONS: There was no statistically significant association between the use of statins and the diagnosis of interstitial lung disease. However there was a statistically significant association between ischaemic heart disease and the diagnosis of ILD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196502     DOI: 10.1016/j.rmed.2009.01.004

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

Authors:  Jin-Fu Xu; George R Washko; Kiichi Nakahira; Hiroto Hatabu; Avignat S Patel; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; Alejandro A Diaz; Hui-Ping Li; Jie-Ming Qu; Blanca E Himes; Carolyn E Come; Katherine D'Aco; Fernando J Martinez; MeiLan K Han; David A Lynch; James D Crapo; Danielle Morse; Stefan W Ryter; Edwin K Silverman; Ivan O Rosas; Augustine M K Choi; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

2.  Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.

Authors:  Hiroyuki Kamide; Shingo Kato; Keigo Hayakawa; Kazuki Fukui; Hideya Kitamura; Takashi Ogura; Tae Iwasawa; Kazuo Kimura; Kouichi Tamura; Daisuke Utsunomiya
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-28       Impact factor: 2.357

3.  Idiopathic pulmonary fibrosis in Saudi Arabia: Demographic, clinical, and survival data from two tertiary care hospitals.

Authors:  Nahid Sherbini; Maun N Feteih; Siraj O Wali; Omer S Alamoudi; Salem M Al-Faifi; Imran Khalid
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

4.  Interstitial lung disease in a veterans affairs regional network; a retrospective cohort study.

Authors:  Armando Bedoya; Roy A Pleasants; Joel C Boggan; Danielle Seaman; Anne Reihman; Lauren Howard; Robert Kundich; Karen Welty-Wolf; Robert M Tighe
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

5.  LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis.

Authors:  Xiangguang Shi; Yahui Chen; Qingmei Liu; Xueqian Mei; Jing Liu; Yulong Tang; Ruoyu Luo; Dayan Sun; Yanyun Ma; Wenyu Wu; Wenzhen Tu; Yinhuan Zhao; Weihong Xu; Yuehai Ke; Shuai Jiang; Yan Huang; Rui Zhang; Lei Wang; Yuanyuan Chen; Jingjing Xia; Weilin Pu; Honglin Zhu; Xiaoxia Zuo; Yisha Li; Jinhua Xu; Fei Gao; Dong Wei; Jingyu Chen; Wenguang Yin; Qingwen Wang; Huaping Dai; Libing Yang; Gang Guo; Jimin Cui; Nana Song; Hejian Zou; Shimin Zhao; Jörg H W Distler; Li Jin; Jiucun Wang
Journal:  Clin Transl Med       Date:  2022-01

Review 6.  Managing comorbidities in idiopathic pulmonary fibrosis.

Authors:  Blair G Fulton; Christopher J Ryerson
Journal:  Int J Gen Med       Date:  2015-09-22

Review 7.  Idiopathic pulmonary fibrosis: pathogenesis and management.

Authors:  Giacomo Sgalla; Bruno Iovene; Mariarosaria Calvello; Margherita Ori; Francesco Varone; Luca Richeldi
Journal:  Respir Res       Date:  2018-02-22

8.  Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction.

Authors:  Lorna Elise Clarson; Ram Bajpai; Rebecca Whittle; John Belcher; Alyshah Abdul Sultan; Chun Shing Kwok; Victoria Welsh; Mamas Mamas; Christian D Mallen
Journal:  Heart       Date:  2020-02-29       Impact factor: 5.994

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.